PRFX (PRFX) Stock Price & Analysis
PRFX (PRFX) fell 1.14% to USD 0.97 as of September 8, 2026 at 06:59 UTC, according to Nexqual real-time market data.
PRFX last closed at USD 0.97; the session ranged USD 0.95–1 on volume of 51,281 shares. Market capitalization is —, with a 52-week range of USD 0.91–7.95 (NCM). Source: Nexqual, September 8, 2026 at 06:59 UTC.
Key Statistics (as of September 8, 2026 at 06:59 UTC)
| Price | USD 0.97 |
|---|---|
| Change | ▼ 1.14% (down) |
| Previous Close | USD 0.97 |
| Open | USD 0.97 |
| Day Range | USD 0.95 – 1 |
| 52-Week Range | USD 0.91 – 7.95 |
| Volume | 51,281 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (PRFX)
Nexqual's technical model rates PRFX "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:59 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.12 (neutral) |
| vs SMA50 | Below (USD 1.13) |
| MACD | -0.05 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AUUD | Auddia Inc. | USD 1 | ▼ 2.91% |
| BJDX | Bluejay Diagnostics, Inc. | USD 0.83 | ▼ 1.96% |
| SPRC | SciSparc Ltd. | USD 5.29 | ▼ 9.57% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
| RNAZ | TransCode Therapeutics, Inc. | USD 2.06 | ▲ 2.49% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:59 UTC. This page is informational and not investment advice.